1. Abbink P, Lemckert AA, Ewald BA, Lynch DM, Denholtz M, Smits S, Holterman L, Damen I, Vogels R, Thorner AR, O’Brien KL, Carville A, Mansfield KG, Goudsmit J, Havenga MJ, Barouch DH (2007) Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 81(9):4654–4663. doi: 10.1128/jvi.02696-06
2. Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaitre B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmuller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA (2016) Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med 374(17):1647–1660. doi: 10.1056/NEJMoa1502924
3. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traore A, Kolie M, Malano ER, Heleze E, Bocquin A, Mely S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Gunther S (2014) Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371(15):1418–1425. doi: 10.1056/NEJMoa1404505
4. Bolay F (2016) A randomized controlled trial of the safety and immunogenicity of two Ebola vaccines. In: Abstracts of the 23rd Conference on Retroviruses and Opportunistic Infections, John B Hynes Veterans Memorial Convention Center, Boston, 22–25 Feb 2016. Abstract 76LB. CROI Foundation/International Antiviral Society-USA, San Francisco, CA. http://www.croiconference.org/sessions/randomized-controlled-trial-safety-and-immunogenicity-two-ebola-vaccines . Accessed 7 Apr 2017
5. Bray M, Chertow DS (2016) Epidemiology and pathogenesis of Ebola virus disease. UpToDate, Wolters Kluwer. https://www.uptodate.com/contents/epidemiology-and-pathogenesis-of-ebola-virus-disease?source=search_result&search=bray%20ebola&selectedTitle=3~23 . Accessed 10 Apr 2017